Tags

Type your tag names separated by a space and hit enter

Dyslipidemia in the metabolic syndrome in children.
J Cardiometab Syndr. 2006 Summer; 1(4):282-5.JC

Abstract

The high triglyceride/low high-density lipoprotein cholesterol phenotype is a component of the metabolic syndrome. The obesity epidemic has increased the prevalence of this abnormality. Recognition of this dyslipidemia is increasingly common in pediatric practice. Treatment includes weight management, including the prevention of future excess weight gain, and exercise. Pharmacologic management is rarely required.

Links

Publisher Full Text

Authors+Show Affiliations

Gidding SS
A. I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA. sgidding@nemours.org

MeSH

AdolescentCardiovascular DiseasesChildCholesterol, HDLDiabetes MellitusDietDyslipidemiasExerciseHealth BehaviorHumansHypolipidemic AgentsLife StyleMetabolic SyndromeObesityPrevalenceRisk AssessmentRisk FactorsTriglycerides

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

17679808

Citation

Gidding, Samuel S.. "Dyslipidemia in the Metabolic Syndrome in Children." Journal of the Cardiometabolic Syndrome, vol. 1, no. 4, 2006, pp. 282-5.
Gidding SS. Dyslipidemia in the metabolic syndrome in children. J Cardiometab Syndr. 2006;1(4):282-5.
Gidding, S. S. (2006). Dyslipidemia in the metabolic syndrome in children. Journal of the Cardiometabolic Syndrome, 1(4), 282-5.
Gidding SS. Dyslipidemia in the Metabolic Syndrome in Children. J Cardiometab Syndr. 2006;1(4):282-5. PubMed PMID: 17679808.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dyslipidemia in the metabolic syndrome in children. A1 - Gidding,Samuel S, PY - 2007/8/8/pubmed PY - 2007/8/31/medline PY - 2007/8/8/entrez SP - 282 EP - 5 JF - Journal of the cardiometabolic syndrome JO - J Cardiometab Syndr VL - 1 IS - 4 N2 - The high triglyceride/low high-density lipoprotein cholesterol phenotype is a component of the metabolic syndrome. The obesity epidemic has increased the prevalence of this abnormality. Recognition of this dyslipidemia is increasingly common in pediatric practice. Treatment includes weight management, including the prevention of future excess weight gain, and exercise. Pharmacologic management is rarely required. SN - 1559-4564 UR - https://www.unboundmedicine.com/medline/citation/17679808/Dyslipidemia_in_the_metabolic_syndrome_in_children_ L2 - https://doi.org/10.1111/j.1559-4564.2006.05798.x DB - PRIME DP - Unbound Medicine ER -